New Enhancing CLIA Act: What Lab Directors Need to Know
The proposal seeks to move any future LDT authority away from the FDA
Already a member? Log in here
CMS-lir
Subscribe today for access to
Articles and Reports
How to Stay Ahead of Anticipated CLIA Deficiencies
Consultant Nora Hess offers suggestions for clinical labs to navigate these problems
Already a member? Log in here
Four Federal Efforts to Monitor, Including RESULTS Act Progress
Other proposals aim to increase fraud enforcement, temper prior authorization, and modernize CLIA
Already a member? Log in here
Palmetto Relents on Some New Molecular Prices
...
Already a member? Log in here
Interim CMS Molecular Pricing Setting Off Alarms
...
Already a member? Log in here
Aetna Cutting Lab Rates Well Below Medicare
...
Already a member? Log in here
OIG Recommends Medicare Payment Cuts
...
Already a member? Log in here
Inside the Lab Industry: MAAA Pricing Dominates Medicare Lab Meeting
...
Already a member? Log in here
Molecular Pricing Improves on Average, But Many Tests Not Priced at All
...
Already a member? Log in here
Ongoing Reimbursement Cuts Have United Laboratory Sector
...
Already a member? Log in here
LabCorp CEO Demurs During Earnings Call, Is Blunt at Lab Institute
...
Already a member? Log in here